Galanin Receptor Ligand M35 TFA llin G potassium CC(C)[C@H]1C2=CC=C(F)C=C2CC[C@@]1(CCN(C)CCCC1NC2=CC=CC=C2N=1)OC(=O)C1CC1

CC(C)[C@H]1C2=CC=C(F)C=C2CC[C@@]1(CCN(C)CCCC1NC2=CC=CC=C2N=1)OC(=O)C1CC1

Tirbanibulin was approved to treat actinic Keratosis of the face or scalp in Dec 2020

Oral administration of Nutlin-3 at 200 mg/kg twice daily for 3 weeks significantly inhibits the tumor growth of SJAS-1 xenografts by 90%

AG 555 (100 μM) inhibits both the early stages (integration process) and the late stages (viral protein synthesis) in the virus life cycle

6]naphthyridin-1(2H)-yl)phenyl)acrylamide

Galanin Receptor Ligand M35 TFA llin G potassium CC(C)[C@H]1C2=CC=C(F)C=C2CC[C@@]1(CCN(C)CCCC1NC2=CC=CC=C2N=1)OC(=O)C1CC1Galanin Receptor Ligand M35 TFA is a high affinity ligand and antagonist of galanin receptor (Kd=0. 1 nM). Galanin Receptor Ligand M35 TFA exerts a Ki values of 0. 11 and 2. 0 nM for human galanin receptor type 1 and 2, respectively. Product information Molecular Weight: 2347. 55 Formula: C109H154F3N27O28 Chemical Name: (S) N1 ((5S, 8S, 11S, 17S, 20S) 1 ((S) 2 ((S) 2 ((S) 2 (2 ((S) 1 ((S) 1 ((S) 2 ((S) 1 ((S) 1 amino 5 guanidino 1 oxopentan 2 ylamino)